Limbaro, Rolando H.

HRN: 10-49-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/20/2025
12/27/2025
IV
4.5g
Q8h
Pneumonia
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines